(Q53231997)

12 May 2018

title

Bone density in women with prolactinoma treated with dopamine agonists. (English)

1 reference

12 May 2018

1 reference

11

Annamaria Colao

1 reference

12 May 2018

author name string

Erika Cesar de Oliveira Naliato

1

1 reference

12 May 2018

Alice Helena Dutra Violante

2

1 reference

12 May 2018

Dayse Caldas

3

1 reference

12 May 2018

Maria Lucia Fleiuss Farias

4

1 reference

12 May 2018

Isabela Bussade

5

1 reference

12 May 2018

Adilson Lamounier Filho

6

1 reference

12 May 2018

Christiane Rezende Loureiro

7

1 reference

12 May 2018

Rosita Fontes

8

1 reference

12 May 2018

Yolanda Schrank

9

1 reference

12 May 2018

Thaissa Loures

10

1 reference

12 May 2018

publication date

1 January 2008

1 reference

12 May 2018

published in

Pituitary

1 reference

12 May 2018

volume

11

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

21-28

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s11102-007-0064-4

exact match

0 references

cites work

Prevalence of osteopenia in men with prolactinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-007-0064-4

Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

21 January 2018

1 reference

12 December 2020

Relationship of leptin to bone mineralization in children and adolescents

1 reference

12 December 2020

Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia

1 reference

12 December 2020

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

12 December 2020

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

1 reference

12 December 2020

Sex steroids and bone

1 reference

12 December 2020

Vertebral bone density in non-amenorrhoeic hyperprolactinaemic women

1 reference

12 December 2020

Prevalence and magnitude of osteopenia in patients with prolactinoma

1 reference

12 December 2020

Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males

1 reference

12 December 2020

Serum leptin level is a predictor of bone mineral density in postmenopausal women.

1 reference

12 December 2020

Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea

1 reference

12 December 2020

Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women

1 reference

12 December 2020

Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels

1 reference

12 December 2020

A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia

1 reference

12 December 2020

Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference

1 reference

12 December 2020

Prolactin release is enhanced in proportion to excess visceral fat in obese women.

1 reference

12 December 2020

Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus)

1 reference

12 December 2020

Effects of prolactin and estrogen deficiency in amenorrheic bone loss

1 reference

12 December 2020

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

1 reference

12 December 2020

Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea

1 reference

12 December 2020

Increase in bone mass after treatment of hyperprolactinemic amenorrhea

1 reference

12 December 2020

10.1007/S11102-007-0064-4

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018